For Medicare beneficiaries prescribed a glucagon-like petide-1 (GLP-1) receptor agonist, eligibility rules are far from ...

GLP-1 microdosing is when people take smaller doses of GLP-1 drugs than are typically prescribed or FDA-recommended, often “on a daily or more frequent basis rather than the standard once-weekly ...

For a very long time, bariatric surgery, in which doctors removed a portion of the stomach, was the standard procedure for helping patients lose weight and manage obesity, alongside metabolic ...

Medicare launched an 18-month pilot program Wednesday called Medicare GLP-1 Bridge, giving eligible participants access to certain GLP-1 medications for $50 per month. While this program is separate ...

GLP-1 drugs can cause side effects such as muscle loss, nutrient deficiencies, nausea, diarrhea, or constipation. GLP-1-friendly foods are marketed to reduce side effects and support treatment. “GLP-1 ...

GLP-1 receptor agonists (RA), such as Ozempic and Mounjaro, were initially designed to help manage blood sugar in type 2 diabetes. Now, they are reshaping the landscape of obesity treatment and ...

Despite growing evidence that GLP-1 medications improve health and are worth their cost, many insurance plans still limit coverage. University of ...

Source: StockSnap / Pixabay GLP-1 medications are effective for the treatment of overweight, obesity, and type 2 diabetes. Emerging evidence has suggested that the GLP-1 medications may also be useful ...